VeriSign, Inc.
300.32USD
-4.2700 (-1.40%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on VRSN.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 1.4B | 1.5B | 1.6B | 1.7B | 1.8B | 1.9B |
| Q1 | 346.9M | 364.4M | 384.3M | 402.3M | 428.9M | 470.2M |
| Q2 | 351.9M | 372.0M | 387.1M | 409.9M | 434.6M | — |
| Q3 | 356.9M | 376.3M | 390.6M | 419.1M | 443.0M | — |
| Q4 | 369.2M* | 380.4M* | 395.4M* | 425.3M | 452.7M | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 6.24 | 7.90 | 8.00 | 8.80 | 9.51 | 10.92 |
| Q1 | 1.43 | 1.70 | 1.92 | 2.10 | 2.34 | 2.63 |
| Q2 | 1.54 | 1.79 | 2.01 | 2.21 | 2.38 | — |
| Q3 | 1.58 | 1.83 | 2.07 | 2.27 | 2.35 | — |
| Q4 | 1.66* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| 2.56* |
| 1.95* |
| 2.20 |
| 2.44 |
| — |
Debt level and coverage